INS and obesity due to melanocortin 4 receptor deficiency: In a follow-up study of children (ages 5–10) born to women who participated in a multicenter trial, there was no reduction found in obesity or metabolic dysfunction in the offspring of women who received treatment (diet therapy and insulin if necessary) compared to those with mild untreated GDM29.